SPINK1 promotes castration resistance in prostate cancer cells

SPINK1 promotes castration resistance in prostate cancer cells

Bibliographic Details
Main Authors:	I. Madueke, W.Y. Hu, L. Xie, D. Vander Griend, M. Abern, G. Prins
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320338313

Similar Items

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
by: Steven Kregel, et al.
Published: (2013-01-01)

The role of SPINK1 in ETS rearrangement-negative prostate cancers.
by: Tomlins, SA, et al.
Published: (2008)

Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
by: Akash K. Kaushik, et al.
Published: (2016-05-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

SPINK4 promotes colorectal cancer cell proliferation and inhibits ferroptosis
by: Bang-li Hu, et al.
Published: (2023-04-01)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
by: Renée de Leeuw, et al.
Published: (2020-10-01)

Chemotherapy options in castration-resistant prostate cancer
by: Benjamin A Teply, et al.
Published: (2016-01-01)

Optimal treatment for castration-resistant prostate cancer
by: Kouji Izumi, et al.
Published: (2014-06-01)

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
by: Ritika Tiwari, et al.
Published: (2020-01-01)

Role of intrapancreatic SPINK1/Spink3 expression in the development of pancreatitis
by: Masaki eOhmuraya, et al.
Published: (2012-05-01)

Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
by: İlkay Gültürk, et al.
Published: (2022-11-01)

Correction: SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression
by: R. Tiwari, et al.
Published: (2021-02-01)

Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.
by: Peizhen Hu, et al.
Published: (2011-01-01)

KIF15 Promotes Progression of Castration Resistant Prostate Cancer by Activating EGFR Signaling Pathway
by: Lin Gao, et al.
Published: (2021-11-01)

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer
by: Alexander W Wyatt, et al.
Published: (2015-04-01)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
by: Ömer Acar, et al.
Published: (2013-01-01)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
by: Teresa Maria Santos Amaral, et al.
Published: (2012-01-01)

Novel Strategies for Treating Castration-Resistant Prostate Cancer
by: David Ka-Wai Leung, et al.
Published: (2021-03-01)

Definition of Castrate Resistant Prostate Cancer: New Insights
by: Juan Morote, et al.
Published: (2022-03-01)

The molecular pathology of Castrate Resistant Prostate Cancer (CRPC)
by: Paul Mainwaring
Published: (2015-12-01)

The role of glutamine metabolism in castration-resistant prostate cancer
by: Bing Zhao, et al.
Published: (2023-01-01)

The resurgence of estrogens in the treatment of castration-resistant prostate cancer
by: H Krishna Moorthy, et al.
Published: (2019-01-01)

PSMA theragnostics for metastatic castration resistant prostate cancer
by: Hong Song, et al.
Published: (2022-08-01)

Radium-223 in metastatic castration resistant prostate cancer
by: Winston Vuong, et al.
Published: (2014-06-01)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015-06-01)

Castration-resistant prostate cancer: potential targets and therapies
by: Parray A, et al.
Published: (2012-08-01)

Castration-resistant prostate cancer: systemic therapy in 2012
by: Fernando C. Maluf, et al.
Published: (2012-01-01)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Mostaghel EA
Published: (2014-01-01)

New developments in the treatment of castration resistant prostate cancer
by: Roxanne Wadia, et al.
Published: (2014-08-01)

State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
by: Elena Castro, et al.
Published: (2014-11-01)

Association and diagnostic value of serum SPINK4 in colorectal cancer
by: Mingzhi Xie, et al.
Published: (2019-04-01)

Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer
by: Sadia Sarwar, et al.
Published: (2024-08-01)

GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer
by: Lilin Wan, et al.
Published: (2023-10-01)

PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer
by: Tianyan Wang, et al.
Published: (2022-03-01)

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
by: Yan Li, et al.
Published: (2022-10-01)

CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
by: Xi Chen, et al.
Published: (2022-12-01)

Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance
by: İvo Gökmen, et al.
Published: (2024-12-01)

NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation
by: Guijiang Sun, et al.
Published: (2024-10-01)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
by: Hess David, et al.
Published: (2010-05-01)